“All patients were terminal state LC (Liver Cirrhosis) patients. Two third in 51 had the ascitis and more than one third had hepatic encephalopathy. After single stem cell therapy using UCBSC (Umbilical Cord Blood Stem Cell), most of the hepatic encephalopathy patients and more than two third of ascitic patients were improved in symptom or responded to medical therapy who were refractory to previous therapy… Stem cell therapy serves for prolongation of the life and improvement of quality of life.”